Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Short-term Investments came in at $528.6 million in Q1 2026, up 980.23% year-on-year from $48.9 million in Q1 2025, and up 51.52% quarter-over-quarter from $348.9 million in Q4 2025.
Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Short-term Investments across 7 years of filings, most recently posting $528.6 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $528.6 million, up 980.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $528.6 million (up 980.23% YoY), and the FY2025 annual result was $348.9 million, up 337.92% from the prior year.
- Short-term Investments came in at $528.6 million for Q1 2026 at Hims & Hers Health, up from $348.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $528.6 million in Q1 2026 to a low of $20.0 million in Q2 2025.
- The 5-year median for Short-term Investments is $132.9 million (2022), against an average of $159.1 million.
- Across the five-year window, Short-term Investments sank 79.56% in 2025 and soared 980.23% in 2026, its largest moves.
- Hims & Hers Health's Short-term Investments stood at $132.9 million in 2022, then declined by 6.42% to $124.3 million in 2023, then tumbled by 35.92% to $79.7 million in 2024, then surged by 337.92% to $348.9 million in 2025, then soared by 51.52% to $528.6 million in 2026.
- The last three Short-term Investments figures came in at $528.6 million (Q1 2026), $348.9 million (Q4 2025), and $284.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 528.61 Mn |
| Dec 31, 2025 | 348.88 Mn |
| Sep 30, 2025 | 283.97 Mn |
| Jun 30, 2025 | 20.03 Mn |
| Mar 31, 2025 | 48.94 Mn |
| Dec 31, 2024 | 79.67 Mn |
| Sep 30, 2024 | 88.55 Mn |
| Jun 30, 2024 | 98.00 Mn |
| Mar 31, 2024 | 98.36 Mn |
| Dec 31, 2023 | 124.32 Mn |
| Sep 30, 2023 | 154.50 Mn |
| Jun 30, 2023 | 127.73 Mn |
| Mar 31, 2023 | 135.65 Mn |
| Dec 31, 2022 | 132.85 Mn |
| Sep 30, 2022 | 140.43 Mn |
| Jun 30, 2022 | 139.94 Mn |
| Mar 31, 2022 | 154.77 Mn |
| Dec 31, 2021 | 175.49 Mn |
| Sep 30, 2021 | 187.65 Mn |
| Jun 30, 2021 | 210.18 Mn |